These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 9072302

  • 1. Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation.
    Soldatenkov VA, Dritschilo A, Wang FH, Olah Z, Anderson WB, Kasid U.
    Cancer J Sci Am; 1997; 3(1):13-20. PubMed ID: 9072302
    [Abstract] [Full Text] [Related]

  • 2. Antisense raf oligodeoxyribonucleotide is a radiosensitizer in vivo.
    Gokhale PC, McRae D, Monia BP, Bagg A, Rahman A, Dritschilo A, Kasid U.
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):191-201. PubMed ID: 10355825
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation.
    Cioffi CL, Garay M, Johnston JF, McGraw K, Boggs RT, Hreniuk D, Monia BP.
    Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592
    [Abstract] [Full Text] [Related]

  • 4. Raf-1 is a necessary component of the mitogenic response of the human megakaryoblastic leukemia cell line MO7 to human stem cell factor, granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 9.
    Brennscheidt U, Riedel D, Kölch W, Bonifer R, Brach MA, Ahlers A, Mertelsmann RH, Herrmann F.
    Cell Growth Differ; 1994 Apr; 5(4):367-72. PubMed ID: 7519043
    [Abstract] [Full Text] [Related]

  • 5. The mitogenic response of T cells to interleukin-2 requires Raf-1.
    Riedel D, Brennscheidt U, Kiehntopf M, Brach M, Herrmann F.
    Eur J Immunol; 1993 Dec; 23(12):3146-50. PubMed ID: 8258328
    [Abstract] [Full Text] [Related]

  • 6. Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells.
    Pirollo KF, Hao Z, Rait A, Ho CW, Chang EH.
    Biochem Biophys Res Commun; 1997 Jan 03; 230(1):196-201. PubMed ID: 9020045
    [Abstract] [Full Text] [Related]

  • 7. RAF antisense oligonucleotide as a tumor radiosensitizer.
    Kasid U, Dritschilo A.
    Oncogene; 2003 Sep 01; 22(37):5876-84. PubMed ID: 12947394
    [Abstract] [Full Text] [Related]

  • 8. Correlation of constitutive activation of raf-1 with morphological transformation and abrogation of tyrosine phosphorylation of distinct sets of proteins in human squamous carcinoma cells.
    Patel BK, Ray S, Whiteside TL, Kasid U.
    Mol Carcinog; 1997 Jan 01; 18(1):1-6. PubMed ID: 9022807
    [Abstract] [Full Text] [Related]

  • 9. First- and second-generation antisense inhibitors targeted to human c-raf kinase: in vitro and in vivo studies.
    Monia BP.
    Anticancer Drug Des; 1997 Jul 01; 12(5):327-39. PubMed ID: 9236850
    [No Abstract] [Full Text] [Related]

  • 10. Antisense inhibition of the RAD51 enhances radiosensitivity.
    Taki T, Ohnishi T, Yamamoto A, Hiraga S, Arita N, Izumoto S, Hayakawa T, Morita T.
    Biochem Biophys Res Commun; 1996 Jun 14; 223(2):434-8. PubMed ID: 8670299
    [Abstract] [Full Text] [Related]

  • 11. Antisense raf oligodeoxyribonucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: implication for gene therapy of radioresistant cancer.
    Gokhale PC, Soldatenkov V, Wang FH, Rahman A, Dritschilo A, Kasid U.
    Gene Ther; 1997 Dec 14; 4(12):1289-99. PubMed ID: 9472552
    [Abstract] [Full Text] [Related]

  • 12. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J, Killian M, Brysch W, Schlingensiepen KH, Kneba M.
    Biochem Biophys Res Commun; 1994 Apr 15; 200(1):661-7. PubMed ID: 7909438
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics, toxicity, and efficacy of ends-modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic liposome.
    Gokhale PC, Zhang C, Newsome JT, Pei J, Ahmad I, Rahman A, Dritschilo A, Kasid UN.
    Clin Cancer Res; 2002 Nov 15; 8(11):3611-21. PubMed ID: 12429653
    [Abstract] [Full Text] [Related]

  • 14. Abrogation of c-Raf expression induces apoptosis in tumor cells.
    Lau QC, Brüsselbach S, Müller R.
    Oncogene; 1998 Apr 09; 16(14):1899-902. PubMed ID: 9583688
    [Abstract] [Full Text] [Related]

  • 15. Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells.
    Mewani RR, Tian S, Li B, Danner MT, Carr TD, Lee S, Rahman A, Kasid UN, Jung M, Dritschilo A, Gokhale PC.
    Int J Mol Med; 2006 Mar 09; 17(3):457-63. PubMed ID: 16465392
    [Abstract] [Full Text] [Related]

  • 16. Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies.
    Dritschilo A, Huang CH, Rudin CM, Marshall J, Collins B, Dul JL, Zhang C, Kumar D, Gokhale PC, Ahmad A, Ahmad I, Sherman JW, Kasid UN.
    Clin Cancer Res; 2006 Feb 15; 12(4):1251-9. PubMed ID: 16489081
    [Abstract] [Full Text] [Related]

  • 17. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo.
    Monia BP, Sasmor H, Johnston JF, Freier SM, Lesnik EA, Muller M, Geiger T, Altmann KH, Moser H, Fabbro D.
    Proc Natl Acad Sci U S A; 1996 Dec 24; 93(26):15481-4. PubMed ID: 8986837
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene.
    Ohnishi T, Taki T, Hiraga S, Arita N, Morita T.
    Biochem Biophys Res Commun; 1998 Apr 17; 245(2):319-24. PubMed ID: 9571148
    [Abstract] [Full Text] [Related]

  • 19. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B, Zupi G.
    Cancer Res; 1998 Jan 15; 58(2):283-9. PubMed ID: 9443406
    [Abstract] [Full Text] [Related]

  • 20. Nucleotide sequence analysis of c-raf-1 cDNA and promoter from a radiation-resistant human squamous carcinoma cell line: deletion within exon 17.
    Patel BK, Kasid U.
    Mol Carcinog; 1993 Jan 15; 8(1):7-12. PubMed ID: 8352893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.